Stocks of Merck & Co Inc (NYSE:MRK) traded higher last session on Wall Street, down -1.83% to $76.17.
MRK stock price is now -7.08% away from the 50-day moving average and -22.10% away from the 200-day moving average. The market capitalization of the company currently stands at $191.27B.
With the price target maintained at $84, Citigroup recently Downgraded its rating from Buy to Neutral for Merck & Co Inc (NYSE: MRK). On April 22, 2025, Cantor Fitzgerald recently initiated its ‘Neutral’ rating on the stock quoting a target price of $85, while ‘Deutsche Bank’ rates the stock as ‘Hold’
In other news, Smart Dalton E. III, SVP Fin. – Global Controller sold 4,262 shares of the company’s stock on Apr 25 ’25. The stock was sold for $352,723 at an average price of $82.76. Upon completion of the transaction, the SVP Fin. – Global Controller now directly owns 7,778 shares in the company, valued at $0.59 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Apr 25 ’25, Officer DALTON SMART bought 4,262 shares of the business’s stock. A total of $352,723 was incurred on buying the stock at an average price of $82.76. A total of 0.07% of the company’s stock is owned by insiders.
During the past 12 months, Merck & Co Inc has had a low of $73.31 and a high of $134.63. As of last week, the company has a debt-to-equity ratio of 0.72, a current ratio of 1.41, and a quick ratio of 1.16.
The net profit margin was 27.33% and return on equity was 39.31% for MRK. The company reported revenue of $15.53 billion for the quarter, compared to $15.78 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -1.56 percent.
